The healthcare landscape is experiencing a shift with the emergence of GLP-1 delivery devices. These innovative formulations offer a potential alternative to administering glucagon-like peptide-1 drugs for individuals managing type 2 diabetes . Instead of daily shots , a easy-to-use patch affixed